🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out these post-doc positions available at the University of Southampton, Cardiff University School of Biosciences and Uni of Nottingham #WeAreUoN on our Jobs page! balr.co.uk/jobs-1

Last week, our team made a splash at #EBROW25, presenting 4 posters on our work to improve understanding and outcomes for bronchiectasis. Topics included use of electronic health records to accelerate diagnoses, pathogen detection assays, and our work in integrated diagnostics.

📢 Join us for the #Bronchiectasis2025 Patient Conference! This event is an opportunity for anyone with an interest in #bronchiectasis to hear insights from patients and learn about the latest research updates from the experts. 📌 Register: europeanlung.org/en/get-involve… ERS

An excellent conference!

🏆 At #EBROW25, we celebrate the future of #bronchiectasis research! 🌟 Abstract presenters engaged with experts & peers in the poster session. 👏 🎉 4 outstanding abstracts won the Best Poster Award & will attend #EBROW27 for free! Congrats! 🎊 #MedicalResearch

please come and join us for the ELF patient conference!

The ERJ is calling for outstanding papers in the field of chronic suppurative lung disease (CF, bronchiectasis and PCD), with one particularly outstanding paper to be presented on behalf of the ERJ at major upcoming international events. ow.ly/twJI50VjasX

RPGR regulates motile cilia by interfering with actin dynamics biorxiv.org/content/10.110…

last chance! Submit your papers to the ERJ!

▶️You can now watch recordings from our #Bronchiectasis2025 Patient Conference on our website! 💡 Listen to patients and experts as they discuss the reality of living with #bronchiectasis, its cross-infection risks and the latest research. 🔗 europeanlung.org/en/get-involve…

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, may lower the rate of pulmonary exacerbations in patients with bronchiectasis. Findings from the ASPEN phase 3 trial are summarized in a short video. nej.md/4jhMNPA

Thank you ATS Blue Journal for highlighting the brilliant Emma Johnson as an emerging investigator in this months Blue Journal for her groundbreaking work on anti-inflammatory treatments for bronchiectasis #proud #simplythebest

Thanks to Emma Johnson, MBBS, MSc, PhD, for her contribution to the May issue Broad Immunomodulatory Effects of the DPP1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial Emma Johnson bit.ly/3GQmGkg

Very exciting to see ReCode Therapeutics preclinical data published! Inhaled DNAI1 mRNA therapy for treatment of primary ciliary dyskinesia | PNAS pnas.org/doi/10.1073/pn…

The new EMBARC bronchiectasis website is live Join us for bronchiectasis news, information and take part in a fantastic community bronchiectasis.net/news/ Join us also on Linkedin- linkedin.com/company/embarc… Stefano Aliberti Kara Robertson ERS European Lung Foundation

On international clinical trials day we say thank you to all of the patients participating in bronchiectasis research to find new treatments and understand more about the disease #bronchiectasis EMBARC Stefano Aliberti Merete Long Holly Lind Dr. Kateryna Viligorska European Lung Foundation

✨️100 participants consented to the BRILLIANT study✨️ A huge effort from the team here in Dundee and 100 amazing participants willing to give their time to take part in our research (and get a bronchoscopy)! Celebrating the only way we know how to.. with CAKE 🍰

Celebrating recruiting 100 patients to the BRILLIANT study 🎉 with cilia videos of course!! Over 250 brushings processed 🔬 A huge team effort so thank you to everyone involved and to all the participants 💚

Congratulations Mathieu Bottier, PhD

An opportunity for people with bronchiectasis (and their carers) to ask questions and get excellent, evidence-based advice from international experts Join us for #worldbronchiectasisday